214 related articles for article (PubMed ID: 15690253)
1. Glycemic control and the risk of multiple microvascular diabetic complications.
Schellhase KG; Koepsell TD; Weiss NS
Fam Med; 2005 Feb; 37(2):125-30. PubMed ID: 15690253
[TBL] [Abstract][Full Text] [Related]
2. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes.
Vijan S; Hofer TP; Hayward RA
Ann Intern Med; 1997 Nov; 127(9):788-95. PubMed ID: 9382399
[TBL] [Abstract][Full Text] [Related]
3. Diabetic complications. The importance of glucose control.
Skyler JS
Endocrinol Metab Clin North Am; 1996 Jun; 25(2):243-54. PubMed ID: 8799699
[TBL] [Abstract][Full Text] [Related]
4. The Association of Obesity and Microvascular Complications with Glycemic Control in Patients with Type 2 Diabetes Mellitus.
Bijelic R; Balaban J; Milicevic S; Sipka SU
Med Arch; 2020 Feb; 74(1):14-18. PubMed ID: 32317828
[TBL] [Abstract][Full Text] [Related]
5. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
6. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.
Sözmen EY; Sözmen B; Delen Y; Onat T
Arch Med Res; 2001; 32(4):283-7. PubMed ID: 11440784
[TBL] [Abstract][Full Text] [Related]
7. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus.
Demirtunc R; Duman D; Basar M; Bilgi M; Teomete M; Garip T
J Diabetes Complications; 2009; 23(2):89-94. PubMed ID: 18358749
[TBL] [Abstract][Full Text] [Related]
8. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.
Abraira C; Duckworth W; McCarren M; Emanuele N; Arca D; Reda D; Henderson W;
J Diabetes Complications; 2003; 17(6):314-22. PubMed ID: 14583175
[TBL] [Abstract][Full Text] [Related]
9. Subclassification of preproliferative diabetic retinopathy and glycemic control: relationship between mean hemoglobin A1C value and development of proliferative diabetic retinopathy.
Sato Y; Lee Z; Hayashi Y
Jpn J Ophthalmol; 2001; 45(5):523-7. PubMed ID: 11583677
[TBL] [Abstract][Full Text] [Related]
10. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
Luk AO; Ma RC; Lau ES; Yang X; Lau WW; Yu LW; Chow FC; Chan JC; So WY
Diabetes Metab Res Rev; 2013 Jul; 29(5):384-90. PubMed ID: 23463747
[TBL] [Abstract][Full Text] [Related]
11. Blood glucose control and microvascular and macrovascular complications in diabetes.
Hanssen KF
Diabetes; 1997 Sep; 46 Suppl 2():S101-3. PubMed ID: 9285509
[TBL] [Abstract][Full Text] [Related]
12. [Not Available].
Keller U
Ther Umsch; 2017; 74(8):454-461. PubMed ID: 29461146
[No Abstract] [Full Text] [Related]
13. Renal Complication and Glycemic Control in Korean Veterans with Type 2 Diabetes: A 10-Year Retrospective Cohort Study.
Kim YA; Lee Y; Seo JH
J Diabetes Res; 2020; 2020():9806790. PubMed ID: 32685562
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program.
Salvotelli L; Stoico V; Perrone F; Cacciatori V; Negri C; Brangani C; Pichiri I; Targher G; Bonora E; Zoppini G
J Diabetes Complications; 2015; 29(8):1066-70. PubMed ID: 26227575
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Neuropathy, Glycemic Control, and Revascularization as Risk Factors for Future Lower Extremity Amputation among Diabetic Patients.
Goldman MP; Corriere MA; Craven T; Davis RP; Sheehan M; Hurie JB; Velazquez G; Williams TK; Chang K; Edwards MS
Ann Vasc Surg; 2021 May; 73():254-263. PubMed ID: 33248240
[TBL] [Abstract][Full Text] [Related]
16. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
[TBL] [Abstract][Full Text] [Related]
17. Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications.
Bashir M; Elhadd T; Dabbous Z; Gul W; Salameh O; Siddiqui M; Al-Muhannadi H; Petropoulos I; Khan A; Ponirakis G; Malik RA
Diabetes Metab Syndr; 2021; 15(5):102241. PubMed ID: 34390975
[TBL] [Abstract][Full Text] [Related]
18. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
[TBL] [Abstract][Full Text] [Related]
19. Visit-to-Visit HbA
Li S; Nemeth I; Donnelly L; Hapca S; Zhou K; Pearson ER
Diabetes Care; 2020 Feb; 43(2):426-432. PubMed ID: 31727686
[TBL] [Abstract][Full Text] [Related]
20. Glycemic variability and diabetes retinopathy: a missing link.
Hsu CR; Chen YT; Sheu WH
J Diabetes Complications; 2015 Mar; 29(2):302-6. PubMed ID: 25534877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
